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Original article

Myeloperoxidase-mediated protein lysine oxidation generates 2aminoadipic acid and lysine nitrile in vivo
Hongqiao Lin, Bruce S. Levison, Jennifer A. Buﬀa, Ying Huang, Xiaoming Fu, Zeneng
Wang, Valentin Gogonea, Joseph A. DiDonato, Stanley L. Hazen
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Recent studies reveal 2-aminoadipic acid (2-AAA) is both elevated in subjects at risk for diabetes and
mechanistically linked to glucose homeostasis. Prior studies also suggest enrichment of protein-bound 2-AAA
as an oxidative post-translational modiﬁcation of lysyl residues in tissues associated with degenerative diseases
of aging. While in vitro studies suggest redox active transition metals or myeloperoxidase (MPO) generated
hypochlorous acid (HOCl) may produce protein-bound 2-AAA, the mechanism(s) responsible for generation of 2AAA during inﬂammatory diseases are unknown. In initial studies we observed that traditional acid- or basecatalyzed protein hydrolysis methods previously employed to measure tissue 2-AAA can artiﬁcially generate
protein-bound 2-AAA from an alternative potential lysine oxidative product, lysine nitrile (LysCN). Using a
validated protease-based digestion method coupled with stable isotope dilution LC/MS/MS, we now report
protein bound 2-AAA and LysCN are both formed by hypochlorous acid (HOCl) and the MPO/H2O2/Cl− system
of leukocytes. At low molar ratio of oxidant to target protein Nε-lysine moiety, 2-AAA is formed via an initial Nεmonochloramine intermediate, which ultimately produces the more stable 2-AAA end-product via sequential
generation of transient imine and semialdehyde intermediates. At higher oxidant to target protein Nε-lysine
amine ratios, protein-bound LysCN is formed via initial generation of a lysine Nε-dichloramine intermediate. In
studies employing MPO knockout mice and an acute inﬂammation model, we show that both free and proteinbound 2-AAA, and in lower yield, protein-bound LysCN, are formed by MPO in vivo during inﬂammation.
Finally, both 2-AAA and to lesser extent LysCN are shown to be enriched in human aortic atherosclerotic plaque,
a tissue known to harbor multiple MPO-catalyzed protein oxidation products. Collectively, these results show
that MPO-mediated oxidation of protein lysyl residues serves as a mechanism for producing 2-AAA and LysCN in
vivo. These studies further support involvement of MPO-catalyzed oxidative processes in both the development
of atherosclerosis and diabetes risk.

1. Introduction
2-Aminoadipic acid (2-AAA) is a low abundance amino acid
previously suggested as an intermediate in some minor pathways of
lysine catabolism in humans [1,2]. Interest in this relatively uncommon
amino acid has increased recently, however, due to its suggested
enrichment both in disease-associated tissues and plasma in subjects
at risk for development of diabetes. For example, using an untargeted
metabolomics approach, Gerszten and colleagues recently reported that

plasma levels of 2-AAA herald increased future risk of developing
diabetes [3]. Moreover, physiological levels of 2-AAA were shown to
promote pancreatic beta cell insulin secretion and lower plasma glucose
levels in murine models, further suggesting potential involvement of 2AAA as a modulator of glucose homeostasis [3]. In earlier studies it was
suggested that protein lysyl residue oxidation by myeloperoxidase
(MPO) – generated halogenating oxidants [4–10] may serve as a
possible mechanism for generation of 2-AAA as a post translational
modiﬁcation of protein and lipoprotein lysyl residues [11]. Subsequent

Abbreviations: m/z, mass to charge; MPO, myeloperoxidase; 2-AAA, 2-aminoadipic acid; LysCN, lysine nitrile; Ac-Lys, Nα-acetyl-lysine; Ac-2AAA, Nα-acetyl-2-aminoadipic acid; AcLysCN, Nα-acetyl-lysine nitrile; PMN, polymorphonuclear leukocytes; PMA, Phorbol 12-myristate 13-acetate; TG, thioglycollate; ZM, zymosan

studies by both our group and Monnier and colleagues suggested not
only MPO, but also metal catalyzed oxidative processes may participate
in 2-AAA formation [11–14]. Indeed, protein bound 2-AAA has been
reported to be enriched at sites known to harbor enhanced levels of
protein oxidation products, including high density lipoprotein recovered from human atherosclerotic lesions, and insoluble collagen from
aged skin, particularly from subjects with diabetes or renal disease [11–
14]. Interestingly, while biosynthetic pathways for generating 2-AAA
are not observed in mammals, 2-AAA is a reported intermediate in the
synthesis of lysine in certain fungi, as well as in the biosynthesis of
penicillin in β-lactam-producing fungi [15,16]. It has also been
reported as a metabolite produced from bacteria of the genus
Thermus [17]. Despite the association between 2-AAA levels and the
risk for developing diabetes [3], and its potential links to both vascular
disease and degenerative diseases of aging [11–14], neither direct
demonstration of oxidative pathway(s) that may participate in 2-AAA
formation in vivo in mammals, nor detailed investigation of the
biochemical pathway and structural intermediates involved in 2-AAA
formation from protein lysyl residues, have been reported.
Wilson and colleagues recently reported that the major product of
protein lysyl residue oxidation by reagent hypochlorous acid (HOCl) is
not 2-AAA, but instead the unusual adduct lysine nitrile (LysCN, 2amino-5-cyanopentanoic acid) [18]. While these purely in vitro studies
used a high HOCl relative to target (protein lysyl residue) ratio, they
reported up to 80% yield of LysCN when a maximal HOCl to target ratio
is used (~100 to 600-fold excess) [18]. Nitriles in general can be acid
labile [19], and acid hydrolysis was used in all (including our own)
prior reported studies detecting protein-bound 2-AAA enrichment in
tissues [11–14]. These provocative results suggesting LysCN as a
potential HOCl generated oxidation product of protein lysyl residues
therefore raised concerns to us of whether protein-bound 2-AAA is even
a post translational oxidation product that exists in vivo, and whether
2-AAA is formed by the MPO/H2O2/Cl- system in vivo.
In this paper we report on our pursuit to elucidate the products and
reaction mechanisms of protein lysyl residue oxidation by HOCl [6,20–
25], MPO-generated chlorinating oxidants [4,5,7–10], and activated
leukocytes both in vitro and in animal models employing wild type
(WT) and MPO knockout (MPO-KO) mice. The studies presented herein
establish that 2-AAA is a major, and LysCN a minor, post translational
oxidation product of lysyl residues formed at sites of inﬂammation. Our
studies further demonstrate substantial enrichment of both 2-AAA and
LysCN within human aortic atherosclerotic plaque, a site previously
shown to harbor enriched content of both MPO and alternative MPOgenerated oxidation products [5,10,26–29], and elucidate the reaction
pathway responsible for MPO-generated chlorinating oxidants in forming these lysine oxidation products.

2. Materials and methods
2.1. Materials
Nα-Boc-L-Lysine and Nα-acetyl-L-Lysine used as surrogates for
protein lysyl residues were purchased from Chem-Impex
International, Inc. (Wood Dale, Illinois). D3-2-aminoadipic acid was
purchased from C/D/N isotopes Inc. (Pointe-Claire, Quebec). 13C6,
15
N2-Lysine was purchased from Cambridge isotope laboratories, Inc.
(Andover, Massachusetts). Sodium hypochlorite (NaOCl), H2O2, ammonium hydroxide (NH4OH), triﬂuoroacetic acid and organic solvents
were obtained from Fisher Scientiﬁc Co. Pronase was purchased from
Roche life science (Indianapolis, Indiana). SAX SPE cartridges were
obtained from Jordi lab (Mansﬁeld, Massachusetts). Axis-Shield
Polymorphprep was purchased from Cosmo Bio USA (Carlsbad,
California). All other materials were obtained from Sigma-Aldrich,
unless otherwise indicated.

2.2. Ethical considerations
All animal model studies were approved by the Institutional Animal
Care and Use Committee of the Cleveland Clinic. All study protocols
and informed consent for human subjects were approved by the
Cleveland Clinic Institutional Review Board. Informed consents were
obtained for isolation of human MPO, neutrophils and all other subject
samples.
2.3. General procedures
In vitro oxidation reactions were performed in 50 mM phosphate
buﬀer (PB), pH=7.0 supplemented with 100 μM diethylene triamine
pentaacetic acid (DTPA). The concentrations of NaOCl and H2O2 were
determined spectrophotometrically (Ԑ292 (NaOCl)=350 M−1 cm−1
[30] and (Ԑ240 (H2O2) =39.4 M−1 cm−1 [31]). Human MPO was
isolated, characterized and quantiﬁed as described [7]. Human neutrophils were isolated by ﬁcoll-hypaque buoyant density centrifugation
as described previously [32]. Phorbol myristate acetate was prepared in
dimethyl sulfoxide (DMSO). Cell experiments were performed in Hanks’
balanced salt solution, pH 7.2 (no calcium, magnesium, or phenol red)
(Thermo Fisher) with 100 μM DTPA.
2.4. Clinical specimens
Human aortic tissues were recovered at the time of vascular or heart
transplantation surgery. All tissues were rinsed in ice-cold normal saline
immediately, submerged in buﬀer (65 mM sodium phosphate, pH 7.4,
100 μM DTPA, 100 μM butylated hydroxytoluene), snap frozen with
liquid N2 and stored at −80 °C under argon until used for analysis.
2.5. Synthesis of lysine nitrile, Nα-acetyl-2-aminoadipic acid, Nα-acetyllysine nitrile
Lysine nitrile (2-amino-5-cyanopentanoic acid) synthesis was carried out according to the method of Yamazaki [33] with modiﬁcations.
Generally, NaOCl (4.5 mmol) was added to the stirring solution of NαBoc-L-Lysine (500 mg, 2 mmol) in ethanol (10 mL). The mixture was
stirred at room temperature for 24 h. Afterwards, the reaction mixture
was poured into H2O (50 mL) and then was extracted with dichloromethane (CH2Cl2, 3×30 mL). The solution was concentrated by rotary
evaporation and the residue puriﬁed on a silica gel column and eluted
with CH2Cl2. The Boc blocking group was removed with a solution of
50% triﬂuoroacetic acid in CH2Cl2. The resultant lysine nitrile was
analyzed by high resolution mass spectrometry (MS) and showed the
anticipated elemental composition and fragmentation pattern. The
theoretical exact mass to charge ratio (m/z) for LysCN
[MH]+(C6H22N2O2) is 143.0821 au, the detected m/z was
[MH]+=143.0820 au, Δppm=0.4 au.
Nα-acetyl-2-aminoadipic acid (Ac-2AAA) was synthesized following
the method of Ravindranath [34]. Due to the low solubility of 2-AAA in
water, triethylamine (TEA) (6 mmol) was added to H2O (2 mL) to
solubilize 2-AAA (320 mg, 2 mmol). Acetic anhydride (4 mmol) was
then added and the mixture was sonicated for 30 min in an FS60 sonic
water-bath (Fisher Scientiﬁc). This process was repeated after adding
another aliquot of acetic anhydride (4 mmol). After sonication, the Ac2AAA was puriﬁed by reverse phase HPLC. The product was conﬁrmed
by high resolution MS analysis and showed the anticipated elemental
composition and fragmentation pattern (m/z [M-H]−=202.0715 au
and the theoretical exact mass ([M-H]−) of Ac-2AAA=202.0715 au,
Δppm=0.0 au).
Nα-acetyl-lysine nitrile (Ac-LysCN) was synthesized by adding
NaOCl (5 mM) to Nα-Ac-Lys (2 mM) in 50 mM sodium phosphate,
pH=7.0. The solution was heated at 40 °C for 72 h. Ac-LysCN was
isolated from the solution by reverse phase HPLC and dried under
reduced pressure in a vacuum centrifuge. The product was analyzed by

high resolution MS and showed the anticipated elemental composition
and fragmentation pattern (m/z=183.0769 au; theoretical exact mass
[M-H]−=183.0770 au, Δppm=0.07 au).
2.6. High performance liquid chromatography for isolating Ac-2AAA and
Ac-LysCN
HPLC separation of Ac-2AAA and Ac-LysCN were performed using
preparative C18 columns (10×250 mm, 5 µm particle diameter,
Beckman, Ultrasphere ODS) pre-equilibrated with solvent A (0.1%
propionic acid in water, pH=3.3). Products were monitored by
absorbance (A205) and eluted at a ﬂow rate of 4 mL/min with a
nonlinear gradient generated with solvent B (0.1% acetic acid in
methanol) as follows: 0–5% solvent B for 5 min; 5–100% solvent B
for 10 min; isocratic 100% solvent B for 4 min. The pH of the mobile
phase was ~2.0. For solid phase extraction (SPE) we loaded the column
with sample in 1% NH4OH (pH=11) and eluted with 1% formic acid
(pH=2.7).
2.7. Lysine nitrile stability test
1 mM LysCN was incubated with either 6N HCl at 110 °C or 4N
NaOH at 120 °C in a sand bath. At the indicated times the reactions
were cooled in an ice bath and then processed with strong anion
exchange (SAX) solid phase extraction (SPE) and further analyzed by
HPLC with online electrospray ionization tandem mass spectrometry
(LC/MS/MS).
2.8. Examining the mechanism of Nα-Acetyl-L-Lysine oxidation by HOCl
Ac-Lys was used as the target for HOCl oxidation. Three diﬀerent
ratios of oxidant to target were used: 1 mM HOCl to 1 mM Ac-Lys (1:1),
2 mM HOCl to 1 mM Ac-Lys (2:1), and 1 mM HOCl to 1 M (pH 7.0) AcLys (1:1000). All of the oxidation reactions were performed in 50 mM
PB, pH 7.0. The formation of monochloramine (RNHCl) and dichloramine (RNCl2) intermediates were monitored by UV at 254 nm or
304 nm, respectively [7]. The decay of RNHCl and RNCl2 was measured
by HPLC with a photodiode array detector, by monitoring the absorbance (A254 for RNCl and A304 for RNCl2). HPLC with on line triple-TOF
mass spectrometry (AB Sciex tripleTOF 5600 system, Framingham, MA)
was used to analyze and quantify Ac-Lys, Ac-2AAA and Ac-LysCN in the
reaction. We used N-acetyl-glutamic acid (Ac-Glu) as an internal
standard and calibration curves were prepared using varying Ac2AAA and Ac-LysCN levels and a ﬁxed amount of internal standard
Ac-Glu. At the indicated times, internal standard (20 μL Ac-Glu,
100 μM) was mixed with 20 μL reaction solution. A portion (5 μL) of
the mixture was injected onto a silica column (2.0×150 mm, 5 µm
particle, Phenomenex Luna silica) at a ﬂow rate of 0.2 mL/min with the
following HPLC gradient: 100% solvent A (0.1% propionic acid in H2O)
for 5 min; 0–100% solvent B (0.1% propionic acid in methanol) for
5 min; isocratic a 100% solvent B for 3 min; 100-0% solvent B for
2 min; the column was then equilibrated with 100% A for 10 min. The
quantity of each analyte was measured by peak area corresponding to
their exact mass relative to peak area of internal standard. TripleTOF
MS was auto calibrated after every three injections.
In order to identify the proposed reaction intermediates, the
TripleTOF mass spectrometer was set to simultaneously scan analytes
with an exact mass to charge ratio from 100 to 1000 in the reaction, as
well as the product ion of the identiﬁed compounds. The identities of
the intermediates were conﬁrmed by matching the exact mass of the
precursor and the potential product ions with the proposed compounds,
as well as their fragmentation patterns.
2.9. Protein enzymatic digestion

Protein samples were ﬁrst dialyzed against 10 mM Tris buﬀer,

pH=7.5 prior to enzymatic digestion. The digestion (1 mg protein/
mL) was carried out in 0.1 M Tris, pH=7.5 and 10 mM CaCl2. To the
reaction solutions we added stable isotope labeled internal standards
(d3-2-AAA, and [13C6, 15N2]Lys) prior to addition of protease. Samples
were pre-warmed at 45 °C in a water bath and the digestion started with
pronase addition (speciﬁc activity=7 unit/mg). The same amount of
pronase (50 μg/mL) was added to the reaction every four hours to a
ﬁnal concentration of 300 μg/mL at the 20th hour. The digestion was
stopped 24 h after the ﬁrst addition of pronase by cooling on ice, and
then by adding 2 mL of 1% ammonium hydroxide to the solution,
followed by solid phase extraction (SPE) column chromatography.
Digested samples were analyzed by LC/MS/MS following addition of
internal standards.

2.10. Quantiﬁcation of protein lysine oxidation products after exposure to
chlorinating oxidants
Three diﬀerent chlorinating oxidant systems were used: (i) reagent
HOCl; (ii) the MPO/H2O2/Cl- system; (iii) and activated human
neutrophils. Human serum albumin (HSA) (1 mg/mL or 15 μM) was
used as a source of protein for oxidation studies. HOCl or H2O2 (for the
MPO/H2O2/Cl− system) was used at molar ratios from 1/8 to equal
amount of protein target as indicated (1.9–15 μM). When using the
MPO/H2O2/Cl- oxidation system, ﬁnal reaction conditions included
32 nM of isolated human MPO and 100 mM of Cl-. For oxidation
reactions using neutrophils, 1×106/mL isolated human neutrophils
were incubated with HSA and, where indicated, activated by addition
of 200 nM (ﬁnal) phorbol-12-myristate-13-acetate (PMA). Neutrophils
were maintained in suspension at 37 °C for 2 h by intermittent
inversion. The media used was Hank's balance salt solution (pH was
7.4, and the chloride concentration was approx. 140 mM). All reactions
were terminated by adding 2 mM methionine. After reaction, recovered
HSA was placed in hydrolysis tubes, internal standards for mass
spectrometry quantiﬁcation were added, and then subjected to protease
digestion for protein bound lysine, 2-AAA, and LysCN quantiﬁcation by
LC/MS/MS.

2.11. Mouse inﬂammation model
Age and sex-matched C57BL/6 J (wild type, WT) and MPO knockout (MPO-KO) mice (back-crossed > 50 generations onto C57BL/6 J)
were used for peritonitis model studies [35]. Mice were intraperitoneally injected with 1 mM 4% thioglycollate (TG) broth to recruit
neutrophils. After twenty hours, the mice received a second intraperitoneal injection with zymosan (250 mg/kg). Four hours later peritoneal lavage was collected with PBS containing 100 μM DTPA and
100 μM butylated hydroxytoluene. In control groups, normal saline
(1 mL) was injected intraperitoneally, and peritoneal lavage was
collected after 24 h. Lavage ﬂuid was separated from cells by centrifugation at 800×g for 10 min at 4 °C, overlaid with argon, and (both cells
and supernatants) stored at −80 °C until analysis.
2.12. Sample preparation for quantiﬁcation of protein bound 2-AAA and
LysCN
After protease digestion, the sample mixture was diluted with 2 mL
1% ammonium hydroxide solution. This solution was passed over a
mini SAX SPE cartridge (3.0 mL, 25–35 µm, 60 mg; Jordi lab), which
was pre-equilibrated with 2×2 mL methanol followed by 2×2 mL 1%
NH4OH solution. Columns were washed with 2×2 mL H2O and
2×2 mL 70% methanol, and amino acids were eluted with 2×2 mL
70% methanol supplemented with 1% formic acid. The eluted solution
was dried under speed vacuum, and then reconstituted in 100 μL H2O
for LC/MS/MS.

2.13. Sample preparation for quantiﬁcation of free 2-AAA and LysCN

3.2. Quantiﬁcation of 2-AAA and LysCN in biological samples

Ice cold methanol (80 μL) containing 10 μM [13C6, 15N2]Lys (universally labeled lysine, u-Lys) and 1 μM d3-2AAA were added to 20 μL
mouse lavage ﬂuid. The protein in the lavage was pelleted by
centrifugation and the free amino acids in the supernatant were
analyzed by LC/MS/MS.

To address the issue of LysCN conversion to 2-AAA during sample
preparation we used enzymatic proteolytic digestion to break down the
protein into its constituent amino acids under conditions where both 2AAA and LysCN are stable. Subsequently, we developed a mass
spectrometry (MS)-based assay to accurately quantify both 2-AAA and
LysCN in biological samples. For complete proteolytic digestion of
proteins extracted from tissue or plasma we used a series of small
amounts (relative to target protein mass) of pronase, a mixture of
proteases from Streptomyces griseus, to break the peptide bonds releasing free amino acids (see Materials and m ethods). We validated the
eﬃciency of the pronase proteolytic method employed by comparing
the digestion yield of various amino acids against conventional acid
hydrolysis of the same amount of human serum albumin (HSA) or
precipitated plasma protein. We considered HCl hydrolysis as complete,
and deﬁned pronase proteolytic eﬃciency as the ratio of amino acid
amounts recovered from pronase digestion to acid hydrolysis. We
eliminated contributions from pronase self-digestion by including
control studies with every batch to allow subtraction of amino acid
amounts recovered in parallel pronase self-digestion reactions (also
ensuring amino acids monitored and subtracted were less than 10%
total observed in complete reaction samples under the conditions
employed). Our control studies revealed that under the methods
employed, the overall recovery yield of various amino acids was in
excess of 90%: (e.g. Met 91 ± 1%, Lys 95 ± 1%, Phe 94 ± 3%, Tyr 91
± 2%, Leu 93 ± 3%, Arg 93 ± 3%, Val 97 ± 2%). An accurate
recovery estimate for Trp could not be obtained because there is only
one Trp residue in HSA, and the self (pronase) enzyme digestion under
the conditions employed was observed to contribute > 10% to the Trp
pool. Additional control studies exposing LysCN and 2-AAA to the same
proteolytic conditions showed that both compounds are stable with 99
± 2% and 102 ± 4% recovery, respectively.

2.14. Mass spectrometry analyses
Lysine, 2-AAA, and LysCN were quantiﬁed by LC/MS/MS.
Calibration curves were prepared using varying concentrations of
lysine, 2-AAA, and synthetic LysCN with a ﬁxed amount of stable
isotope-labeled internal standards [13C6, 15N2]Lys and d3-2-AAA respectively. Internal standards were added to each sample prior to
sample preparation, which underwent enzymatic digestion and SAX
solid phase extraction. The sample (5 μL) was injected onto a silica
column (4.6×250 mm, Clipeus silica 5 µm, Higgins Analytical Inc,
Mountain view, CA) at a ﬂow rate of 0.8 mL/min. Separation was
performed using the following gradient: start with solvent A (0.1%
propionic acid aqueous solution); 0–15% solvent B (methanol containing 0.1% acetic acid) for 10 min; 15–100% solvent B for 1 min; isocratic
with 100% solvent B for 3 min; 0–100% solvent A for 1 min; equilibration of the column with solvent A for 15 min. After 3.9 min the HPLC
column eﬄuent was introduced into an API 4000 QTRAP mass spectrometer, and after 11 min the HPLC eﬄuent was diverted to waste. The
mass spectrometer was set to acquire data from 4 min to 10 min.
Analyses were performed using electrospray ionization in positive-ion
mode with multiple reaction monitoring of characteristic precursor and
product ions speciﬁc for the components monitored. The transitions
monitored were mass-to-charge ratio (m/z): 147→84 for lysine; 162→
98, and 162→55 for 2-AAA; 143→97, and 143→54 for LysCN, and
155→90 for [13C6, 15N2]Lys; and ﬁnally 165→101 for d3-2AAA.
2.15. Statistical analysis
The statistical signiﬁcance of diﬀerences was determined using the
Kruskal–Wallis test by ranks (one-way ANOVA on ranks) [36]. P values
less than 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Conventional acid or base protein hydrolysis methods convert LysCN
into 2-AAA
As noted above, debate exists in the ﬁeld of lysyl residue oxidation
chemistry. Recent studies suggest LysCN may be the major stable
posttranslational modiﬁcation of lysine formed in vivo, based upon in
vitro studies examining proteins exposed to excess HOCl [18]. We
therefore ﬁrst sought to investigate whether prior studies used protein
hydrolysis methods that would accurately measure LysCN and 2-AAA in
tissues. LysCN was synthesized as outlined under Materials and
Methods and both its stability and the stability of 2-AAA examined
during typical protein hydrolysis conditions (either 6N HCl, 110 °C; or
4N NaOH, 120 °C). Of note, LysCN was virtually quantitatively
converted into 2-AAA under both acid and base hydrolysis conditions
(Fig. 1A and B). Thus, typical protein hydrolysis conditions are not
appropriate to accurately quantify either protein-bound LysCN or 2AAA in biological samples. These results also suggested that ours and
others’ previously published studies used conditions during sample
preparation (e.g. Refs. [3,11–14]) that may have inadvertently overestimated the 2-AAA content because a portion (or all) of the measured
2-AAA may have come from the hydrolysis of LysCN, if it is present in
the sample. Of further note, however, as far as we are aware, no studies
to date have reported detection of protein-bound LysCN in vivo.

3.3. The mechanism of Nα−protected lysyl residue oxidation by HOCl
To understand the chemistry and clarify the products of posttranslational modiﬁcation of protein lysyl residues by MPO, we initially
investigated lysine oxidation by the major MPO-generated oxidant,
HOCl. In these initial mechanistic studies we used Nα-acetyl-lysine (AcLys) as a protein lysyl residue surrogate. The acetyl group was used to
protect the α-amine group of lysine from oxidation and to mimic the
peptide bond. Following the reaction of Nα-Ac-Lys with HOCl, we
discovered that both Nα-acetyl-2-aminoadipic acid (Ac-2AAA) and Nαacetyl-lysine nitrile (Ac-LysCN) were formed. Moreover, we determined
that Ac-2AAA is the major oxidation product in this reaction when a
lower molar ratio of HOCl: Ac-Lys is used, whereas at higher oxidant to
target exposures, the amount of Ac-LysCN increases and becomes the
major product (Figs. 2–4). Previous work has already established that
the reaction of HOCl with the backbone α–amino group of free amino
acids and side chain amino groups produce chloramine reaction
intermediates [24,25,37–39]. Our results suggest that Ac-2AAA is
produced through a monochloramine reaction intermediate, while AcLysCN might be formed through a dichloramine intermediate –
hypotheses subsequently conﬁrmed in our studies (see below).
We ﬁrst examined both the stoichiometry and time course of
reaction products formed during interaction of Ac-Lys with HOCl as
described under Materials and methods. Results at 1 mol oxidant
(HOCl) to 1 mol target (Nα-Ac-Lys) are shown in Fig. 2. Consistent
with previous studies showing that the ε-amine group of lysine readily
reacts with HOCl forming Nα-Ac-Nε-chloro-lysine (RNHCl) [7,24,38–
41], we observed that Ac-Lys was rapidly consumed, and an intermediate, RNHCl absorbing at 254 nm, forms and then decays (Fig. 2).
Monitoring the reaction using high-pressure liquid chromatography
(HPLC) coupled with both a photodiode array detector and mass
spectrometry analyses revealed that RNHCl decays into a longer-lived

Fig. 1. LysCN stability under acid hydrolysis and base hydrolysis conditions. LysCN (1 mM) was incubated with either 6N HCl at 110 °C or 4N NaOH at 120 °C. At the indicated times, 2AAA and LysCN content in the reaction were analyzed by LC/MS/MS following solid phase extraction (SPE) as described under Materials and methods. A, Lysine nitrile (Δ) is not stable
under conventional acid hydrolysis condition and quantitatively decomposes to 2-AAA (Ο). B, Lysine nitrile (Δ) is not stable under base hydrolysis conditions and quantitatively
decomposes to 2-AAA (Ο). Data shown represent the mean +/− S.D. of duplicated determinations for a study performed greater than three independent times.

Fig. 2. Nα-acetyl-LysCN is the major product in the reaction of Nα-acetyl-lysine with
equal moles of HOCl. HOCl (1 mM) was added to Nα-acetyl-lysine (1 mM) in reaction
buﬀer (see Materials and methods for details). Initial Nα-acetyl-lys-NHCl (Δ) production
was monitored by UV 254 nm. Nα-acetyl-lys-NCl2 (Ο) decay was measured by HPLC-UV
at 304 nm. All analyte identities (including mono- and di-chloramines) were conﬁrmed by
high resolution mass spectrometry analyses. Nα-acetyl-lys (◊), Nα-acetyl-lysCN (×), Nαacetyl-2-AAA (□) were quantiﬁed by LC-Triple-TOF mass spectrometer as described
under Materials and methods. Data shown represent the mean +/− S.D. of duplicated
determinations for a study performed greater than three independent times.

intermediate, Nα-Ac-Nε-dichloro-lysine (RNCl2) that absorbs at 304 nm.
Furthermore, separate studies starting with RNHCl and mass spectrometry (MS) analyses indicated rapid formation of Ac-Lys and RNCl2,
consistent with a disproportionation reaction of RNHCl [42].
Ultimately, RNCl2 decays too as the reaction proceeds [37], leading

Fig. 3. Nα-acetyl-LysCN is the major product in the reaction of Nα-acetyl-lysine with
2 mol of HOCl. Nα-acetyl-lysine (1 mM) was incubated with HOCl (2 mM) in reaction
buﬀer and reaction products formed monitored as described in Materials and methods. All
analyte identities (including di-chloramine) were conﬁrmed by high resolution mass
spectrometry analyses. Nα-acetyl-lys-NCl2 (Ο) decay was measured by UV at 304 nm. Nαacetyl-lys (◊), Nα-acetyl-lysCN (×), were quantiﬁed by LC-Triple-TOF mass spectrometer.
Data shown represent the mean +/- S.D. of duplicated determinations for a study
performed greater than three independent times.

to Ac-LysCN as the main product and a small amount of Ac-2AAA
(Fig. 2). When the oxidant to Ac-Lys ratio is increased to 2:1 (HOCl: NαAc-Lys; Fig. 3), Ac-Lys is completely consumed shortly after adding
HOCl rapidly forming the dichloramine [37], which then further
decomposes into Ac-LysCN.
Lysine is one of the most abundant amino acids in proteins (about 1

The MS/MS spectra of the two detected molecules (Fig. 5A and B)
indicate that these two compounds have identical anticipated elemental
composition and fragmentation patterns as the expected imine and
semialdehyde intermediates. For example, the measured masses of the
parents and their fragment ions (see Fig. 5A and B for proposed
fragmentation pattern) are all less than 2 ppm from the theoretical
masses, strongly supporting the identity of these proposed labile
intermediates. The existence of these two compounds in the oxidation
reaction strongly supports our proposed pathway for Ac-2AAA formation.
3.4. Human serum albumin lysyl residue oxidation by HOCl and the MPO/
H2O2/Cl- system

Fig. 4. Nα-acetyl-2-AAA is the major product in the reaction of Nα-acetyl-lysine with
HOCl (1000:1 M ratio). HOCl (1 mM) was reacted with Nα-acetyL-lysine (1 M). The
reactions were performed in reaction buﬀer as described in Materials and m ethods. All
analyte identities (including mono-chloramine) were conﬁrmed by high resolution mass
spectrometry analyses. Nα-acetyl-lys-NHCl (Ο) decay was measured by UV at 254 nm. Nαacetyl-lysCN (Δ), Nα-acetyl-2-AAA (□) were quantiﬁed by LC-Triple-TOF mass spectrometer. Data shown represent the mean +/− S.D. of duplicated determinations for a study
performed greater than three independent times.

in 5 residues), but under physiological conditions the amount of
oxidant produced by MPO is typically much less than the amount of
lysine. At sites of inﬂammation one would expect monochloramines to
be rapidly scavenged by free and protein-bound thiol [43–45]. This is
because methionine and cysteine preferentially react with HOCl orders
of magnitude faster than lysine [24,46]. Therefore it is reasonable to
assume that under physiological conditions the molar concentration of
MPO-generated oxidants will be orders of magnitude less than that of
lysine ride chains (especially in the extracellular compartment). Thus,
we performed studies where the oxidant is present at only a trace level
relative to protein target ratio (e.g. 1:1000, HOCl: Nα-Ac-Lys), as one
might predict exist in vivo (Fig. 4). Here, the initial RNHCl formed was
observed to decompose into 2-AAA as the major product, and LysCN as
a minor product (Fig. 4). Also observed under these conditions, the
monochloramine intermediate formed is at low level relative to
unreacted Ac-Lys, and the RNHCl disproportionation reaction (forming
RNCl2) does not signiﬁcantly occur.
Based on these results we hypothesized that when Ac-Lys is in a
large molar excess with respect to the oxidant species, Ac-Lys-NHCl
takes a diﬀerent reaction pathway by eliminating HCl with the
formation of an imine intermediate instead of disproportionation. The
imine compound would be relatively unstable and further hydrolyze,
releasing ammonia to form Nα-acetyl-2-aminoadipic–δ–semialdehyde,
which similarly is unstable and reactive in the presence of RNHCl (or
HOCl) and could be further oxidized to Ac-2AAA. This reaction pathway has been established for the reaction of HOCl with the α–amino
groups of free amino acids, but here we were able to directly test
whether this pathway is plausible also for the ε-amino group of lysine
by using high resolution mass spectrometry (see Materials and methods). Both proposed imine and semialdehyde intermediates were
identiﬁed as sequential products formed in the oxidation reaction.

Next we used human serum albumin (HSA) as a target protein
model system to further investigate lysine oxidation by HOCl or
mediated via the action of human MPO (Fig. 6).
Initially, we used a range of HOCl: HSA molar ratios 0–1; HSA 1 mg/
mL (15 µmol), HOCl 0–15 µmol) and observed results similar to those
observed with Ac-Lys oxidation (Fig. 6A) – namely, at a low molar ratio
of oxidant to target ( < 0.3), 2-AAA is the major oxidation product (the
yield of 2-AAA is approx. 1% of the HOCl added) of the stable end
products of lysine oxidation monitored, while LysCN becomes the major
product at a higher molar ratio (the yield of LysCN is approx. 1.3% of
the added HOCl). Nearly identical results were obtained with the
complete MPO/H2O2/Cl- system (Fig. 6B). In additional control studies,
we conﬁrmed that each component of the MPO/H2O2/Cl- system is
required for HSA lysine oxidation to produce protein-bound 2-AAA and
LysCN (H2O2: HSA=0.25, Fig. 7).
3.5. Human neutrophils oxidize protein lysyl residues forming both 2-AAA
(major) and LysCN (minor) as products
MPO is one of the most abundant proteins in neutrophils [4,47].
During neutrophil activation at sites of inﬂammation, MPO is released
and uses H2O2 from respiratory bursts and physiological levels of
chloride to make HOCl [4,47]. We therefore next sought to test whether
activated isolated human neutrophils can employ the MPO system to
oxidize protein lysyl residues and generate 2-AAA and LysCN. HSA was
incubated with human neutrophils in the presence of media containing
physiological levels of chloride followed by PMA stimulation to activate
the neutrophils. DTPA (100 µmol) was also added to the media to
inhibit potential free redox active transition metal ion metal-catalyzed
oxidation. In the presence of this “Complete System” (i.e. HSA,
neutrophils, and PMA), both protein-bound 2-AAA and LysCN were
formed with 2-AAA as the major product (Fig. 8). On the other hand, in
the absence of any one of the components of the oxidation system
(neutrophils, or PMA) or in the presence of an MPO inhibitor (e.g.
azide), no signiﬁcant amount of oxidation products were observed.
Addition of catalase, a scavenger of H2O2, dramatically reduced the
production of both 2-AAA and LysCN, and addition of methionine, a
scavenger of HOCl [24,48,49], also diminished both 2-AAA and LysCN
formation, consistent with neutrophils employing the MPO/H2O2/Clsystem in generation of these post translational modiﬁcations of lysine
(Fig. 8).
3.6. MPO forms 2-AAA and LysCN in vivo at sites of inﬂammation
We further investigated whether MPO is involved in the formation
of 2-AAA and LysCN at sites of inﬂammation in vivo. For these studies
we used MPO-KO mice and an acute inﬂammation model, zymosaninduced peritonitis, that is well characterized and frequently employed
to gauge the role of MPO in protein or lipid oxidation in vivo [35]. As
shown in Fig. 9A, the content of 2-AAA in peritoneal lavage protein
from wild type mice signiﬁcantly (P < 0.001) increases following
thioglycolate (TG)-induced recruitment of leukocytes and zymosan

Fig. 5. Nα-acetyl-lys-imine (A) and Nα-acetyl-2-aminoadipic semialdehyde (B) are detected in the reaction of Nα-acetyl-lys with HOCl (1000:1). Generation of Nα-acetyl-lys-imine and Nαacetyl-2-aminoadipic semialdehyde intermediates were detected by Triple-TOF high resolution mass spectrometry as described under Materials and methods. Exact mass of both
precursor and product ions of the identiﬁed molecules match with those of the calculated masses of the proposed reaction intermediates as shown, respectively.

Fig. 6. Formation of 2-AAA and LysCN in the reaction of HSA with HOCl and MPO/H2O2/Cl- system. Reactions were carried out in reaction buﬀer as described in Materials and methods
with HSA (1 mg/mL) and the indicated concentration of oxidant. Oxidation products were subsequently quantiﬁed by LC/MS/MS following pronase digestion described under Materials
and methods. A, At lower HOCl to protein ratio, 2-AAA is the major product. At higher HOCl to protein ratio, LysCN is the major product. B, When HSA is oxidized by MPO/H2O2/Clsystem, at lower H2O2 to HSA ratio, 2-AAA is the major product; at higher H2O2 to HSA ratio, LysCN is the major reaction product. Data represent the mean ± S.D. of triplicate
determinations for an experiment performed at least 3 separate times.

(ZM) triggered leukocyte activation in WT mice. In sharp contrast,
however, the MPO-KO mice showed no signiﬁcant increase in 2-AAA
following TG and ZM injection. Similarly, a signiﬁcant increase in
protein-bound LysCN is formed in WT mice injected with TG and ZM (P
< 0.001), but not in MPO-KO mice (Fig. 9B). Moreover, while at
baseline similar protein content of 2-AAA and LysCN in peritoneal
lavage proteins were noted, the amount of LysCN produced during
inﬂammation was approximately half that observed for 2-AAA.

3.7. MPO oxidation is a source of free 2-AAA production in vivo
We also examined whether MPO can generate free 2-AAA in vivo.
Here peritoneal lavage supernatants were analyzed for quantiﬁcation of
free 2-AAA and free LysCN. As shown in Fig. 10, after neutrophils were
elicited by TG and activated by ZM, there was a signiﬁcant ~4.5-fold
increase (p < 0.001) in free 2-AAA noted in WT mice over TG treatment
alone. This increase was completely abrogated in MPO-KO mice.
Attempts to measure free LysCN in the lavage ﬂuid failed to demon-

strate any detectable levels in response to any of the treatments. Under
the conditions employed for the assay, the limit of detection (S/N of
peak=3:1) of LysCN was 40 nM.
3.8. Human aortic lesions are enriched in both 2-AAA and LysCN
In the ﬁnal series of studies we sought to test whether 2-AAA and
LysCN are present in normal human aorta and whether levels of these
oxidation products are enriched in aortic atherosclerotic lesions. Using
the validated pronase digestion method we readily detected both
species and observed the content of both protein-bound 2-AAA and
LysCN are elevated in human aortic atherosclerotic plaque compared to
healthy aorta. Fig. 11A and B shows that protein bound 2-AAA and
LysCN content in atherosclerotic lesions are signiﬁcantly higher (~2fold, p < 0.001) than in normal aortic tissue; moreover, the 2-AAA
content in human aortic tissues observed were more than 10-fold higher
(p < 0.005) than that for LysCN.
4. Discussion

Fig. 7. Protein bound 2-AAA and LysCN formation requires protein lysyl residue exposure
to the complete MPO/H2O2/Cl- system. HSA (1 mg/mL, 15 μM) was exposed to the
complete MPO/H2O2/Cl- system, or to the indicated components of the MPO system. The
production of 2-AAA LysCN and oxidation precursor lysine were quantiﬁed by LC/MS/MS
as described in Materials and methods. Only under the complete MPO/H2O2/Cl- system,
2-AAA and LysCN were produced. Data values represent the mean ± S.D. of triplicate
samples for an experiment performed at least 3 separate times.

Fig. 8. Activated human neutrophils employ the MPO/H2O2/Cl- system to oxidize protein
bound lysyl residues to 2-AAA and LysCN. The complete MPO system ( C) consisted of
freshly harvested human neutrophils (PMN) (1×106 cells/mL) activated with 200 nM
phorbol myristate acetate (PMA) in the presence of HSA (1 mg/mL). Where indicated,
either PMN or PMA was omitted; or catalase (20 μg/mL) or methionine (2 mM) was
included with the complete MPO system. Results are the mean ± S.D. of triplicate
determinations for an experiment performed at least 3 separate times.

Our present studies explore the chemistry and the stable terminal
products of protein lysyl residue oxidation by MPO generated chlorinating oxidants in vitro and in vivo. We provide direct evidence that
both 2-AAA and LysCN are posttranslational modiﬁcations of protein
lysyl residues through action of MPO-generated oxidants in vivo.
Moreover, detailed analysis of the reaction mechanism reveals the
following scheme summarized in Fig. 12. First, activated neutrophils or
monocytes generate HOCl, which reacts with the ε–amino group of
protein lysine to produce a Nε−monochloramine as a reaction intermediate [37]. The monochloramine is labile, and can further decompose to form 2-AAA. We suggest that because there is still chlorinating
oxidant capacity of lysine monochloramine, in the presence of excess
protein lysines, as long as it does not get scavenged (e.g. by RSH or RSR
groups) it keeps exchanging halogen to other lysine Nε−amine residues
reforming Nε−monochloramine until it eliminates HCl, forming an
imine intermediate. The latter undergoes subsequent hydrolysis
through the elimination of NH3 and addition of H2O to give the 2aminoadipate−δ−semialdehyde intermediate (Fig. 12).
The semialdehyde intermediate is not stable and rapidly forms 2AAA. Importantly, we were able to directly detect both the indicated
imine and semialdehyde intermediates in the reaction mixture by high
resolution MS, as well as to show direct precursor→product relationships for most of the proposed transitions indicated including starting
from isolated mono-chloramine, further supporting the pathway proposed for the formation of 2-AAA. Our studies further revealed that
when the oxidant to lysine target ratio is higher, the RNHCl formed can
either disproportionate to produce dichloramine RNCl2 intermediate
+lysine, or further react with another HOCl molecule to form the
dichloramine RNCl2 intermediate [37]. This latter intermediate was
isolated and shown to directly decompose into LysCN. Collectively, our
results also help to explain why the prior in vitro study by Sivey et al.
[18,50,51] reported LysCN as the overwhelming product formed without 2-AAA. Our studies show similar results when a comparable vast
molar excess of oxidant is used (~100-fold or more relative to target).
Further, quantitation of each of the products formed under diﬀerent
molar ratios of oxidant to target (Figs. 2–4) is entirely consistent with
the stoichiometry of the reactions shown in Fig. 12. It is of interest to
note that in previous studies we demonstrated that chlorine gas (Cl2)
can be produced by the MPO/H2O2/Cl- system of neutrophils [9]. Cl2 is
in equilibrium with HOCl in water and was directly detected by mass
spectrometry in headspace gas above activated neutrophils [9]. We
therefore include the hypothetical pathway involving Cl2 reaction with
protein lysyl residues leading directly to lysine monochloramine and
dichloramine derivatives as yet another possible pathway envisioned at
high ratios of oxidant to target protein Nε−Lys groups for generation of
LysCN (Fig. 12).

Fig. 9. MPO plays a role in 2-AAA and LysCN formation during inﬂammation. WT and MPO KO mice were injected intra-peritoneally with thioglycollate (TG) broth or vehicle control
(n=6 in each group). Where indicated, zymosan was injected 20 h after injection of TG. Peritoneal lavages were performed 24 h after the initial injection. Protein bound 2-AAA, LysCN
and lysine content in soluble proteins from the peritoneal lavages were determined by LC/MS/MS as described under Materials and methods. Data points shown represent duplicate
analyses of a sample from an individual mouse, reported as μmol oxidation product/mol Lys of either 2-AAA or LysCN, as indicated, and the bar represents mean, the number above the
data points represents mean ± S.D. P-value shown represents Kruskal–Wallis test within the indicated groups of mice. NS=non-signiﬁcant.
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Fig. 10. Free 2-AAA level in zymosan induced peritonitis model. Free 2-AAA in WT and
MPO-KO mouse peritoneal lavage under experimental conditions as described in Fig. 10
were quantiﬁed by stable isotope dilution LC/MS/MS (Materials and methods). Each data
point represents the mean of duplicate analysis of sample from one mouse. Lines indicate
mean levels within each group and values reported represent mean ± S.D. P-value shown
represents Kruskal–Wallis test within the indicated groups of mice. NS=non-signiﬁcant.

Our studies reveal that prior analyses that reported detection of
protein-bound 2-AAA in tissues likely overestimated 2-AAA formation
due to acid catalyzed hydrolysis of protein-bound LysCN into 2-AAA. By
using MPO-KO mice, our studies for the ﬁrst time directly demonstrate
that 2-AAA is a major product of protein lysyl residues oxidation by
MPO at sites of inﬂammation. It should also be noted that in both WT
and MPO-KO mice, protein bound 2-AAA and LysCN were both present
at baseline and at approximately equal levels. Thus, these results
strongly suggest that pathway(s) alternative to MPO also exist for
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Normal
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Fig. 11. Both 2-aminoadipic acid (2-AAA) and lysine nitrile (LysCN) are enriched in
protein recovered from human aortic atherosclerotic tissues compared to normal aorta.
Samples were prepared from normal human aortic tissue (n=5) and atherosclerotic
plaque-laden aortic tissue (n=5). Protein bound 2-AAA and LysCN were quantiﬁed after
protease-mediated hydrolysis by LC/MS/MS mass spectrometric analysis as described
under methods. Data points shown represent duplicate analyses of a sample from an
individual aorta, reported as μmol oxidation product/mol Lys of either 2-AAA or LysCN,
as indicated, and the bar represents mean ± S.D.

generation of these post translational modiﬁcations to protein lysyl
residues. Diﬀerent pathways have been reported to produce 2-aminoadipic-δ-semialdehyde, including metal catalyzed oxidation [52,53], and
lysyl oxidase [54]. Besides MPO mediated oxidation, it is also possible
to form 2-AAA through further oxidation of 2-aminoadipic-δ-semialdehyde. We found MPO catalyzed oxidant of protein lysyl residues is one
pathway producing 2-AAA in inﬂammatory diseases, however further
studies of the origins of 2-AAA in diﬀerent disease states are needed.
Moreover, our studies also show an increase in free 2-AAA in mice
following MPO catalyzed oxidation during inﬂammation. We presume
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Fig. 12. Schematic illustration of reaction pathways for the formation of 2-AAA and LysCN by MPO/H2O2/Cl−(HOCl) oxidation of protein-bound lysine.

the free amino acid is a proteolytic degradation product of an MPOoxidized protein since levels of free 2-AAA were nominal at baseline,
and markedly increased with inﬂammation in the WT but not MPO-KO
mice. It also is noteworthy that in prior reported studies, exposure of
free lysine to HOCl oxidizes lysine at the Nα-amine to form Nαmonochloramine, which then decomposes into a distinct aldehyde
(and not 2-AAA) via a diﬀerent pathway [7,8]. Thus, MPO-catalyzed
generation of free 2-AAA observed in our animal model studies
presumably arose from oxidation of protein-bound Lys, and not free
Lys.
Our ﬁndings thus suggest MPO is a likely source of 2-AAA in vivo.
While not directly examined in the present studies, we suspect MPOmediated oxidation is a major pathway responsible for the elevation of
protein-bound 2-AAA and LysCN in human atherosclerotic plaque, since
MPO and numerous characteristic oxidation products such as 3-chlorotyrosine are enriched in atherosclerotic plaque [27,55]. It is also
notable that numerous studies have shown elevated levels of circulatory
inﬂammatory factors in obese and prediabetic subjects [56], and a
potential role of MPO in diabetes development has been suggested [57].
Inﬂammation of pancreatic islets is proposed to contribute to the
development of type two diabetes [58], and elevated systemic MPO
levels have been reported in patients with diabetes or insulin resistance
[59]. Interestingly, prior studies with MPO-KO mice have shown
protection from high fat diet-induced obesity and insulin resistance
[57]. Based on these cumulative ﬁndings, more studies exploring the
role of MPO, 2-AAA generation and development of insulin resistance
seem warranted. Given the ongoing eﬀort for generation of pharmacological agents that inhibit MPO as a potential therapeutic for the
treatment of atherosclerosis, it will be interesting to see if such agents
also have a potential salutary eﬀect on prevention of prediabetes and
diabetes development.
The present studies focused primarily on chemical mechanisms
responsible for post translational modiﬁcation of protein lysyl residues
and their conversion into 2-AAA and LysCN. The biological consequences of 2-AAA and LysCN formation on target proteins by MPOmediated oxidation are unknown. Under physiological conditions,
lysine's ε-amino side chain is positively charged, and often participates
in hydrogen bonds and salt bridges, which are crucial to protein
structure and function. The modiﬁcation of lysine to 2-AAA alters its
charge from positive to negative, which changes the interaction of this

posttranslationally-modiﬁed lysine with surrounding molecules. It is
thus likely that such oxidative modiﬁcation to a protein could cause
conformational changes at aﬀected local sites, and it can be envisioned
to potentially alter protein function. Considering the high content of
lysine residues in proteins and the low abundance of MPO modiﬁcations, future studies should pay particular emphasis on possible gain of
function modiﬁcations to protein lysine residues mediated by MPO. It is
also
noteworthy
that
the
protein
bound
2aminoadipate−δ−semialdehyde intermediate formed has potential to
crosslink with a second lysyl residue, which also would of course
change protein structure and possibly function. Our studies revealing
the end products of MPO-mediated oxidation of lysine in vivo and the
reaction mechanisms involved can help to better understand potential
functional changes of oxidized proteins found at the sites of inﬂammation in future investigations.
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